Cell Bio Human TechLtd has been growing earnings at an average annual rate of 46.9%, while the Chemicals industry saw earnings declining at 0.09% annually. Revenues have been growing at an average rate of 26% per year. Cell Bio Human TechLtd's return on equity is 14.9%, and it has net margins of 16.7%.
How Cell Bio Human TechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A318160 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
55,525
9,250
8,541
813
31 Dec 25
51,066
8,721
8,364
684
30 Sep 25
45,066
8,478
6,705
656
30 Jun 25
37,609
5,909
5,787
620
31 Mar 25
30,751
5,110
5,072
519
31 Dec 24
28,419
4,379
4,062
486
30 Sep 24
27,817
1,413
3,803
498
30 Jun 24
27,836
890
3,856
528
31 Mar 24
27,968
-1,709
3,634
572
31 Dec 23
27,324
-1,857
3,594
657
30 Sep 23
26,254
-902
3,466
472
30 Jun 23
27,332
994
3,212
619
31 Mar 23
27,092
3,010
3,106
690
31 Dec 22
27,545
2,890
3,088
742
30 Sep 22
28,112
2,564
3,051
990
30 Jun 22
27,080
-144
3,348
876
31 Mar 22
30,492
1,565
3,514
801
31 Dec 21
35,161
3,131
3,632
718
31 Dec 20
28,588
3,776
3,793
467
31 Dec 19
24,103
4,062
3,572
246
31 Dec 18
27,570
9,009
2,243
203
31 Dec 17
18,583
5,159
1,522
346
Quality Earnings: A318160 has a high level of non-cash earnings.
Growing Profit Margin: A318160's current net profit margins (16.7%) are higher than last year (16.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A318160's earnings have grown significantly by 46.9% per year over the past 5 years.
Accelerating Growth: A318160's earnings growth over the past year (81%) exceeds its 5-year average (46.9% per year).
Earnings vs Industry: A318160 earnings growth over the past year (81%) exceeded the Chemicals industry -3.4%.
Return on Equity
High ROE: A318160's Return on Equity (14.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/11 04:40
End of Day Share Price
2026/07/10 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cell Bio Human Tech Co.,Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.